Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.07 per share
-
Shares outstanding
-
12,824,689
-
Total 13F shares
-
2,187,317
-
Share change
-
-328,228
-
Total reported value
-
$31,168,844
-
Put/Call ratio
-
35%
-
Price per share
-
$14.25
-
Number of holders
-
29
-
Value change
-
-$4,415,868
-
Number of buys
-
23
-
Number of sells
-
8
Institutional Holders of MediWound Ltd. - Ordinary shares, par value NIS 0.07 per share (MDWD) as of Q1 2024
As of 31 Mar 2024,
MediWound Ltd. - Ordinary shares, par value NIS 0.07 per share (MDWD) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,187,317 shares.
The largest 10 holders included
Rosalind Advisors, Inc., Yelin Lapidot Holdings Management Ltd., DAFNA Capital Management LLC, Uniplan Investment Counsel, Inc., ESSEX INVESTMENT MANAGEMENT CO LLC, WELLS FARGO & COMPANY/MN, Sargent Investment Group, LLC, Point72 Asset Management, L.P., Silverberg Bernstein Capital Management LLC, and JPMORGAN CHASE & CO.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.